(Q36648456)

15 August 2017

title

Efficacy of topical pimecrolimus in the treatment of chronic vulvar pruritus: a prospective case series--a non-controlled, open-label study (English)

1 reference

15 August 2017

Evren Sarifakioglu

1

1 reference

15 August 2017

Ilknur Inegol Gumus

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Journal of Dermatological Treatment

15 August 2017

published in

1 reference

15 August 2017

volume

17

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

276-278

1 reference

Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09546630600823351

Antipruritic effects of pimecrolimus and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600823351

Subcutaneous injection of triamcinolone acetonide in the treatment of chronic vulvar pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600823351

Occlusive treatment of chronic hand dermatitis with pimecrolimus cream 1% results in low systemic exposure, is well tolerated, safe, and effective. An open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600823351

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600823351

The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600823351

10.1080/09546630600823351

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference